The "Europe Sepsis Diagnostics Market Forecast to 2028 COVID-19 Impact and Regional Analysis By Product, Technology, Method, Test Type, Pathogen, and End User" report has been added to ResearchAndMarkets.com's offering.
The Europe sepsis diagnostics market is expected to grow from US$ 193.12 million in 2021 to US$ 360.55 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028.
Technology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources. In the sepsis diagnosis process, identifying the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. Molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology are majorly used sepsis diagnostics techniques.
Among all, molecular diagnostics (MDx) is an attractive approach to consider for sepsis diagnostics. The increasing adoption of molecular diagnostic technology due to its several advantages, such as high sensitivity, accuracy, and less turnaround time, over other technologies has proved it the gold standard. Therefore, several companies are investing in point-of-care molecular diagnostics to diagnose bacterial and viral pathogens early and for better patient management.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe sepsis diagnostics market. The Europe sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.
Europe Sepsis Diagnostics Market Segmentation
The Europe sepsis diagnostics market is segmented based on product, technology, method, test type, pathogen, end user, and country.
Based on product, the Europe sepsis diagnostics market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media dominated the Europe sepsis diagnostics market in 2021.
Based on technology, the Europe sepsis diagnostics market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment dominated the Europe sepsis diagnostics market in 2021.
Based on method, the Europe sepsis diagnostics market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment dominated the Europe sepsis diagnostics market in 2021.
Based on test type, the Europe sepsis diagnostics market is categorized into point-of-care tests and laboratory tests. The laboratory tests segment dominated the Europe sepsis diagnostics market in 2021.
Based on pathogen, the Europe sepsis diagnostics market is categorized into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment dominated the Europe sepsis diagnostics market in 2021.
Based on end user, the Europe sepsis diagnostics market is categorized into hospitals, pathology and reference laboratories, and others. The hospitals segment dominated the Europe sepsis diagnostics market in 2021.
Based on country, the Europe sepsis diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe sepsis diagnostics market in 2021.
Market Dynamics
Market Drivers
- High Incidence of Sepsis due to Increasing Nosocomial Infections
- Increase in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
Market Restraints
- Absence of Skilled Professionals
Market Opportunities
- Rise in Funding and Support for Sepsis Diagnostics Research
Future Trends
- Growing Technological Advancements in Sepsis Diagnosis
Key Topics Covered:
1. Introduction
2. Key Takeaways
3. Research Methodology
4. Europe Sepsis Diagnostics Market Market Landscape
5. Europe Sepsis Diagnostics Market Key Market Dynamics
6. Sepsis Diagnostics Market- Europe Analysis
7. Europe Sepsis Diagnostics Market By Product
8. Europe Sepsis Diagnostics Market By Technology
9. Europe Sepsis Diagnostics Market By Method
10. Europe Sepsis Diagnostics Market By Test Type
11. Europe Sepsis Diagnostics Market By Pathogen
12. Europe Sepsis Diagnostics Market By End User
13. Europe Sepsis Diagnostics Market By Country Analysis
14. Sepsis Diagnostics Market-Industry Landscape
15. Company Profiles
16. Appendix
Companies Mentioned
- Abbott
- F. Hoffman LaRoche
- Immunexpress Inc.
- BD
- Danaher (Beckman Coulter)
- Luminex Corporation
- Thermo Fisher Scientific INC.
- bioMerieux SA
- T2 Biosystems, Inc
- Axis-Shield Diagnostics Ltd
For more information about this report visit https://www.researchandmarkets.com/r/pfp67j
View source version on businesswire.com: https://www.businesswire.com/news/home/20221018005874/en/
Contacts:
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
